C28H28N6O4
Neat
512.57
2244619-11-0; IBRUTINIB IMPURITY 77; (R)-3-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3, 4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl acrylate; N-Desacryloyl N-(3-Acryloyl-propanoyl) Ibrutinib; Ibrutinib Impurity N11; X69BAM8WM9; 2-Propenoic acid, 3-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3, 4-d]pyrimidin-1-yl]-1-piperidinyl]-3-oxopropyl ester; G87613; 3-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3, 4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl acrylate, (R)-; 3-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3 and 4-d]pyrimidin-1-yl]-1-piperidinyl]-3-oxopropyl 2-propenoate
[3-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3 and 4-d]pyrimidin-1-yl]piperidin-1-yl]-3-oxopropyl] prop-2-enoate
InChI=1S/C28H28N6O4/c1-2-24(36)37-16-14-23(35)33-15-6-7-20(17-33)34-28-25(27(29)30-18-31-28)26(32-34)19-10-12-22(13-11-19)38-21-8-4-3-5-9-21/h2-5,8-13,18,20H,1,6-7,14-17H2,(H2,29,30,31)/t20-/m1/s1